- Home
- CHSCO vs KLTOW Comparison
CHSCO vs KLTOW Comparison
Compare CHSCO & KLTOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHSCO
- KLTOW
- Stock Information
- Founded
- CHSCO N/A
- KLTOW N/A
- Country
- CHSCO United States
- KLTOW United States
- Employees
- CHSCO N/A
- KLTOW 3
- Industry
- CHSCO Farming/Seeds/Milling
- KLTOW Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CHSCO Industrials
- KLTOW Health Care
- Exchange
- CHSCO Nasdaq
- KLTOW Nasdaq
- Market Cap
- CHSCO N/A
- KLTOW N/A
- IPO Year
- CHSCO N/A
- KLTOW 2022
- Fundamental
- Price
- CHSCO $26.01
- KLTOW $0.02
- Analyst Decision
- CHSCO
- KLTOW
- Analyst Count
- CHSCO 0
- KLTOW 0
- Target Price
- CHSCO N/A
- KLTOW N/A
- AVG Volume (30 Days)
- CHSCO N/A
- KLTOW N/A
- Earning Date
- CHSCO N/A
- KLTOW N/A
- Dividend Yield
- CHSCO N/A
- KLTOW N/A
- EPS Growth
- CHSCO N/A
- KLTOW N/A
- EPS
- CHSCO N/A
- KLTOW N/A
- Revenue
- CHSCO N/A
- KLTOW N/A
- Revenue This Year
- CHSCO N/A
- KLTOW N/A
- Revenue Next Year
- CHSCO N/A
- KLTOW N/A
- P/E Ratio
- CHSCO N/A
- KLTOW N/A
- Revenue Growth
- CHSCO N/A
- KLTOW N/A
- 52 Week Low
- CHSCO N/A
- KLTOW N/A
- 52 Week High
- CHSCO N/A
- KLTOW N/A
- Technical
- Relative Strength Index (RSI)
- CHSCO 44.63
- KLTOW N/A
- Support Level
- CHSCO $25.97
- KLTOW N/A
- Resistance Level
- CHSCO $26.32
- KLTOW N/A
- Average True Range (ATR)
- CHSCO 0.32
- KLTOW 0.00
- MACD
- CHSCO 0.02
- KLTOW 0.00
- Stochastic Oscillator
- CHSCO 40.82
- KLTOW 0.00
About CHSCO CHS Inc. Class B Cumulative Redeemable Preferred Stock
CHS Inc is an integrated agricultural enterprise, that provides grain, food, and energy resources to businesses and consumers. Its Energy segment produces and provides wholesale distribution of petroleum products and transportation of those products. Its Ag segment, which is the key revenue driver, purchases and processes or resells grains and oilseeds; serves as a wholesaler and retailer of crop inputs; produces and markets ethanol. Its Nitrogen Production segment consists of equity method investment in CF Nitrogen, which entitles the purchase of up to a specified quantity of granular urea and UAN annually from CF Nitrogen. Geographically, the company derives maximum revenue from North America and the rest from South America, Asia Pacific, Europe, Middle East, and Africa (EMEA).
About KLTOW Klotho Neurosciences Inc. Warrant
Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.